Cannabics Pharmaceutical Inc. (OTCMKTS:CNBX) has released concluding results for its in-vivo study evaluating the efficacy of its novel drug candidate RCC-33 in extending the survival rate...
Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) founded an auxiliary – Digestix Bioscience. The new company will develop pharmaceutical compositions and medical devices to cure early-stage and precancerous neoplastic...